EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
6,394,043
Share change
+119,450
Total reported value
$19,757,785
Put/Call ratio
8.9%
Price per share
$3.09
Number of holders
33
Value change
+$369,364
Number of buys
12
Number of sells
8

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q3 2024

As of 30 Sep 2024, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,394,043 shares. The largest 10 holders included RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, Stonepine Capital Management, LLC, VANGUARD GROUP INC, WASATCH ADVISORS LP, MORGAN STANLEY, PERKINS CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, and KENNEDY CAPITAL MANAGEMENT LLC. This page lists 33 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.